documents: FDA-2014-D-1167-0025
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2014-D-1167-0025 | FDA | FDA-2014-D-1167 | Controlled Correspondence Related to Generic Drug Development; Guidance for Industry; Draft Guidance | Other | Guidance | 2022-12-22T05:00:00Z | 2022 | 12 | 2022-12-22T05:00:00Z | 2023-02-22T04:59:59Z | 2024-03-18T13:33:56Z | 0 | 0 | 090000648554cff7 |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref